Profile
| Metric | Value |
|---|---|
| Full Name | Jasper Therapeutics, Inc. |
| Ticker | NASDAQ: JSPR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | jaspertx.com |
| Employees | 64 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.05 | |
| Price, 1D Change | +7.89% | |
| $57M | ||
| - | ||
| - | ||
| 1.28 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$4.89 | ||
| EPS, 1Y Change | +20.87% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | AMHC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$4.89 | ||
| EPS Estimate | -$4.80 | |
| EPS Est. Change | +1.71% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $2.05 | |
| Price Target | - | $9.50 |
| Price Tgt. Change | - | +363.41% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$6.16 | -$6.18 | -0.25% | |
| -$4.51 | -$4.89 | -8.37% | |
| -$4.80 | N/A | +1.71% | |
| -$3.29 | N/A | +32.57% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.05 | |
| $3.32 | ||
| SMA 200 vs Price | +61.94% | |
| $1.84 | ||
| SMA 50 vs Price | -10.17% | |
| 1.28 | ||
| $0.14 | ||
| 62.60 | ||
| 58.64% | ||
| 113.21% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$4.89 | ||
| -$1.37M | ||
| - | ||
| -$76.24M | ||
| - | ||
| -$71.27M | ||
| - | ||
| -$74.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 4.98 | ||
| 4.98 | ||
| - | ||
| - | ||
| -4.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.96 | ||
| -0.09 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $61.67M | ||
| $71.64M | ||
| $79.90M | ||
| $75.81M | ||
| $15.96M | ||
| $15.24M | ||
| $1.81M | ||
| $1.09M | ||
| $4.03M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $76.24M | ||
| $76.24M | ||
| $1.37M | ||
| $20.42M | ||
| $1.37M | ||
| $0.00 | ||
| -$1.49M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$62.60M | ||
| -$532.00K | ||
| $47.88M | ||
| $552.00K | ||
| -$63.15M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| RBC Capital | → | |
| JMP Securities | → | |
| Evercore ISI Group | → | |
| BTIG | → | |
| UBS | → | |
| JMP Securities | → | |
| Evercore ISI Group | → | |
| BMO Capital | → | |
| William Blair | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with JSPR
Data Sources & References
- JSPR Official Website jaspertx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1788028/000121390025107884/0001213900-25-107884-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1788028/000121390025018384/0001213900-25-018384-index.htm
- JSPR Profile on Yahoo Finance finance.yahoo.com/quote/JSPR
- JSPR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jspr
FAQ
What is the ticker symbol for Jasper Therapeutics, Inc.?
The ticker symbol for Jasper Therapeutics, Inc. is NASDAQ:JSPR
Does Jasper Therapeutics, Inc. pay dividends?
No, Jasper Therapeutics, Inc. does not pay dividends
What sector is Jasper Therapeutics, Inc. in?
Jasper Therapeutics, Inc. is in the Healthcare sector
What industry is Jasper Therapeutics, Inc. in?
Jasper Therapeutics, Inc. is in the Biotechnology industry
What country is Jasper Therapeutics, Inc. based in?
Jasper Therapeutics, Inc. is headquartered in United States
When did Jasper Therapeutics, Inc. go public?
Jasper Therapeutics, Inc. initial public offering (IPO) was on January 10, 2020
Is Jasper Therapeutics, Inc. in the S&P 500?
No, Jasper Therapeutics, Inc. is not included in the S&P 500 index
Is Jasper Therapeutics, Inc. in the NASDAQ 100?
No, Jasper Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Jasper Therapeutics, Inc. in the Dow Jones?
No, Jasper Therapeutics, Inc. is not included in the Dow Jones index
When was Jasper Therapeutics, Inc. last earnings report?
Jasper Therapeutics, Inc.'s most recent earnings report was on November 10, 2025
When does Jasper Therapeutics, Inc. report earnings?
The next expected earnings date for Jasper Therapeutics, Inc. is February 26, 2026